Bowel Preparation for Colonoscopy in Children

• Status: Terminated
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study is to determine whether Miralax results in a more efficacious preparation as compared to senna for pediatric colonoscopy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Hospital of Philadelphia
• Treatments: Polyethylene glycol 3350; Senna Extract; Sennoside A&B

Criteria

Inclusion Criteria:

1. Subjects age 6-21 yrs for senna, PEG-P groups

2. Subjects age 13-21 yrs for NaP group

3. First time colonoscopy

4. Patient weight <70 kg for PEG-P group (to not exceed 51 grams/dose)

Exclusion Criteria:

1. Chronic renal, liver, or heart failure

2. Chronic constipation

3. Patients on the GI inpatient or consult service.

4. Subjects taking senna or PEG on a regular basis for laxative reasons.

5. Pregnant or lactating females